clinical trial updates and time-limited therapy in cll
Published 2 years ago • 377 plays • Length 2:59Download video MP4
Download video MP3
Similar videos
-
3:35
an insight into time-limited therapy in cll
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
1:17
optimizing initial therapy in cll: time-limited, all-oral approaches
-
3:13
selection for time-limited & continuous therapy in cll
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
1:34
time-limited vs continuous therapy in cll treatment
-
1:24
time-limited therapy in cll
-
2:00
the role of fedratinib in 2024 and beyond
-
1:50
targeted therapy in cll in 2022 and in the future
-
2:55
clinical outcomes of patients with cll receiving long-term ibrutinib in the resonate-2 study
-
0:49
considering patient preference when selecting between continuous and time-limited therapy in cll
-
1:56
choosing between continuous and time-limited therapy in patients with high-risk cll
-
1:29
the importance of treatment sequencing in cll
-
2:07
moving towards time-limited treatment in frontline cll
-
1:18
updates from current cll clinical trials
-
1:18
involving the patient in treatment decisions for cll
-
4:57
sequencing of targeted therapies for cll
-
3:46
latest updates in the cll treatment landscape
-
2:20
clinical trial updates in cml